Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5965-5969

  Framme, Carsten ^a   Wolf, Sebastian ^a   Wolf Schnurrbusch, Ute ^a  

^a University Eye Clinic Bern   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MEMBRANE MICROPARTICLE; PHOTORECEPTOR INNER SEGMENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD OUTER SEGMENT; RETINITIS; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; VISUAL ACUITY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; OPHTHALMOSCOPY; RETINA; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 79955992265     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5779     Document Type: Article

References (29)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004;291:1900-1901.
2. Eye Disease Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564-572.
3. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355: 1419-1431.
4. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus Verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
5. Regillo CD, Brown DM, Abraham P, et al. Randomized, doublemasked, sham-controlled trial of ranibizumab for neovascular agerelated macular degeneration: PIER Study year 1. Am J Ophthalmol.2008;145:239-248.
6. Keane PA, Liakopoulos S, Ongchin SC, et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:3115-3120.
7. Golbaz I, Ahlers C, Schütze C, et al. Influence of antiangiogenic therapy on retinal thickness values in age-related macular degeneration (in German). Ophthalmologe. 2009;106:1103-1110.
8. Rothenbuehler SP, Waeber D, Brinkmann CK, Wolf S, Wolf- Schnurrbusch UEK. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol. 2009;147:831-837.
9. Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci. 2009;50:2376-2383.
10. Framme C, Walter A, Prahs P, Regler R, Theisen-Kunde D, Brinkmann R. Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral optical coherence tomography. Curr Eye Res. 2009;34:568-579.
11. Framme C, Panagakis G, Birngruber R. Effects on Choroidal neovascularization after anti-VEGF upload using intravitreal ranibizumab, as determined by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51:1671-1676.
12. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58(3):353-363.
13. Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands. Aktuelle therapeutische Möglichkeiten bei der neovaskulären altersabhängigen Makuladegeneration. Ophthalmologe 2007;104:628-634.
14. Green WR, Sebag J. Vitreoretinal interface. In: Ryan SJ, Wilkinson CP III, eds. Retina. St Louis, MO: Mosby-Year Book Inc; 2001: 1882-1960.
15. Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol. 1985;103:1403-1405.
16. Nguyen-Tan JQ, Thompson JT. RPE cell migration into intact vitreous body. Retina. 1989;9:203-209.
17. Lopez PF, Yan Q, Kohen L, et al. Retinal pigment epithelial wound healing in vivo. Arch Ophthalmol. 1995;113:1437-1446.
18. Hogg PA, Grierson I, Hiscott P. Direct comparison of the migration of three cell types involved in epiretinal membrane formation. Invest Ophthalmol Vis Sci. 2002;43:2749-2757.
19. Crouch ER, Apple DJ. Posttraumatic migration of retinal pigment epithelial melanin. Am J Ophthalmol. 1974;78:251-254.
20. Hilton GF. Subretinal pigment migration: effects of cryosurgical retinal reattachment. Arch Ophthalmol. 1974;91:445-450.
21. Machemer R, LaQua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
22. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci. 1981;21:10-16.
23. Li ZY, Possin DE, Milam AH. Histology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology. 1995;102:805-816.
24. Crafoord S, Kopp ED, Seregard S, Algvere PV. Cellular migration into neural retina following implantation of melanin granules in the subretinal space. Graefes Arch Clin Exp Ophthalmol. 2000; 238:682-689.
25. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115(11): 1883-1890.
26. Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology 2009;116(3):488-496.
27. Sayanagi K, Sharma S, Yamamoto T, Kaiser P Comparison of spectral- domain versus time-domain optical coherence in management of age-related macular degeneration with ranibizumab. Ophthalmology. 2009;116:947-955.
28. Bolz M, Ritter M, Polak K. The role of stratus OCT in anti-VEGF therapy: qualitative and quantitative assessment of neovascular AMD (in German). Ophthalmologe. 2008;105(7):650-655.
29. Kaiser PK, Blodi PA, Shapiro H, Acharya NR. MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114:1868-1875.